Text Module

Share

Program Content

Activities

  • BRCA Testing and PARPi in EBC
    BRCA Testing and the Role of PARP Inhibition in Early Breast Cancer: A Multidisciplinary Roundtable
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 27, 2023

    Expires: March 26, 2024

Faculty

cover img faculity

Constance Albarracin, MD, PhD

Professor
Director, Breast Fellowship Program
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Banu Arun, MD

Professor, Breast Medical Oncology
Co-Director, Clinical Cancer Genetics 
Executive Director, Cancer Genetics
MD Anderson Cancer Networks
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Allison Butts, PharmD, BCOP

Clinical Pharmacy Specialist, Breast Oncology
Pharmacist Manager, Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
UK Healthcare
Lexington, Kentucky

cover img faculity

Emilia Diego, MD, FACS

Division Chief
Division of Breast Surgery
University of Pittsburgh Medical Center
Co-Director
Division of Breast Surgery
UPMC Hillman Cancer Center Breast Program
Pittsburgh, Pennsylvania

cover img faculity

Charles E. Geyer, Jr., MD

Professor of Medicine
Division of Hematology/Medical Oncology
Department of Internal Medicine
University of Pittsburgh UPMC Hillman Cancer Center
Staff Attending
Breast Medical Oncology
UPMC Magee Womens Hospital
Pittsburgh, Pennsylvania

cover img faculity

Marissa Marti-Smith, APRN, AGNP-C, AOCNP

Nurse Practitioner
Breast Oncology
Texas Oncology Baylor Sammons Cancer Center
Dallas, Texas

cover img faculity

Kristen Shannon, MS, CGC

Director
Mass General Cancer Center Genetics Program
Mass General Hospital Cancer Center
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme, LLC

Partners

ProCE

ProCE Banner